ARCHIMED has successfully taken Bomi Group private with a €70 million acquisition, marking the firm's entry into mid-cap healthcare investments.
Target Information
ARCHIMED has successfully completed the take-private acquisition of Bomi Group, securing over 99% of the company's shares following the closure of the official bid period mandated by Italian stock market regulator CONSOB on May 10, 2019. The takeover, valued at approximately €70 million, was initiated on March 1 at a price of €4.00 per share, representing a generous premium of around 31% over Bomi Group's closing price prior to the announcement.
Bomi Group, founded in 1985, has established itself as a leading provider of transport, warehousing, and supply chain management services tailored to the healthcare sector. The firm services a diverse clientele, including pharmaceutical and medical equipment manufacturers, hospitals, testing laboratories, and outpatient service providers, operating in 20 countries across Europe, the Americas, and Asia.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare logistics industry has undergone significant transformation, driven by technological advancements and the increasing demand for efficient supply chain solutions. Countries with advanced healthcare systems, such as Ital
Similar Deals
DUBAG Investment Advisory GmbH → Nabtesco Oclap S.r.l.
2025
Breeze Holdings Acquisition Corp. → D-Orbit S.p.A.
2022
Hitachi Rail Italy Investments S.r.l. → Ansaldo STS S.p.A.
2015
ARCHIMED
invested in
Bomi Group
in 2019
in a Public-to-Private (P2P) deal
Disclosed details
Transaction Size: $70M
Equity Value: $70M